Related Experiment Video
Updated: Mar 16, 2026

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Pharmaceutical services as a tool to improve outcomes in patients with cardiovascular diseases
Damian Swieczkowski1, Mariusz Mogielnicki2, Piotr Merks3
1First Department of Cardiology, Medical University of Gdansk, Debinki 7, 80-211 Gdansk, Poland; Department of Pharmaceutical Technology, Faculty of Pharmacy, Ludwig Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland.
Insights
Community pharmacy services improve cardiovascular patient outcomes like adherence and blood pressure control. Developing evidence-based models and interprofessional collaboration are key to enhancing pharmaceutical care effectiveness.
Area of Science:
- Cardiovascular medicine
- Clinical pharmacy
- Public health
Background:
- Major adverse cardiovascular outcomes remain high despite available treatments.
- Community pharmacy services offer potential benefits for cardiovascular patients.
- Predicting the impact of pharmaceutical interventions is challenging.
Purpose of the Study:
- To highlight the impact of clinical pharmacy activities on cardiovascular patient outcomes.
- To emphasize the need for evidence-based models in pharmaceutical care.
- To identify areas for improvement in pharmaceutical services for cardiovascular diseases.
Main Methods:
- Review of existing literature on clinical pharmacy and cardiovascular care.
- Analysis of factors influencing the effectiveness of community pharmacy interventions.
- Discussion of the role of health literacy and patient-provider communication.
Main Results:
- Pharmaceutical care in community settings positively affects adherence, blood pressure, cholesterol, and health literacy.
- Factors like time spent and communication quality influence intervention outcomes.
- Interprofessional collaboration and pharmacoeconomic analyses are crucial for advancement.
Conclusions:
- Pharmaceutical care provides significant benefits to cardiovascular patients and the healthcare system.
- Developing evidence-based models and enhancing interprofessional collaboration are essential next steps.
- Further research using real-world data is recommended to optimize pharmaceutical services.
Abstract:
Despite the presence of effective and safe pharmacotherapy, and availability of multidimensional non-pharmacological treatment, the overall rate of major adverse cardiovascular outcomes remains still unsatisfactory. The clinical pharmacy activities and pharmaceutical care available in the community pharmacy settings have a significant impact on outcomes in cardiovascular patients, e.g. adherence, the level of blood pressure, total cholesterol or patients' health literacy. Pharmaceutical care in patients diagnosed with cardiovascular diseases remains beneficial both to the patients and the entire health care system. However, the prediction of results of pharmacists' interventions is particularly difficult and random. Many factors contribute to outcomes of community pharmacy services, e.g. time spent with the patients or quality of communication between patients and healthcare professionals. The most important issue in delivering effective pharmaceutical care is to develop an evidence-based model. Globally, the development of interprofessional collaboration between physicians and pharmacists, and preparing more sophisticated pharmacoeconomics analyses in the scope of pharmaceutical care are the next step in the improvement of advanced pharmaceutical services. Further research, particularly based on real data on this highly interesting topic is needed and recommended.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Heart Failure V: Medical Management
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care

